Target intelligence / Profile preview

Mucin glycoprotein layer stabilization

Molecular classification
Glycoprotein, Gel-forming protein, Extracellular matrix protein
01

Overview

The mucin glycoprotein layer is a structurally organized barrier comprised of heavily glycosylated mucin proteins that assemble into a viscoelastic, gel-like matrix at epithelial surfaces. This layer provides lubrication, regulates permeability to particles and pathogens, and acts as a first line of defense in innate immunity. Structural stabilization depends on non-covalent mucin-mucin interactions, extensive O-linked glycosylation, and environmental factors such as pH and ion concentration. Large mucins (e.g., MUC2, MUC5AC, MUC5B) form the structural backbone of the mucus gel, while membrane-associated mucins (e.g., MUC1) reinforce cell surface protection. Defects or alterations in mucin composition and cross-linking are implicated in a range of diseases from cancer to chronic infection and inflammation

Other names
mucin layermucus gel barriermucin stabilizationmucus stabilization
02

Mechanism of action

Agents altering mucin glycosylation, aggregation, or secretion can affect the stabilization of the mucus layer

03

Biological functions

Barrier formationLubricationDefense against pathogensRegulation of particle/molecule permeabilityCell signaling
04

Disease associations

Cancer (especially with overexpression or altered glycosylation pattern of mucins)Infection (defective mucin barrier increases susceptibility)Inflammation (changes in mucin properties contribute to inflammatory diseases)Cystic fibrosis and other conditions involving defective mucus clearance
05

Safety considerations

Unintended disruption of the mucin barrier can increase infection risk and epithelial damageExcess stabilization/mucin overproduction can lead to mucus plugging, as seen in chronic pulmonary diseases
06

Interacting drugs

No approved drugs directly interact with "mucin glycoprotein layer stabilization"; some agents (e.g., mucolytics, recombinant mucins, engineered glycoproteins) attempt to modulate the mucus barrier indirectly
07

Biomarkers

Mucin gene expression (MUC1, MUC2, MUC5AC)Glycosylation patterns and sialylation/ sulfation status

Beyond the preview

Go deeper on Mucin glycoprotein layer stabilization.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Mucin glycoprotein layer stabilization.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call